nlandor
December 24th, 2007, 04:54 PM
Brian Koll, M.D. Chief of Epidemiology at Beth Israel Medical Center was the faculty.
Download video (http://webmedia.ipro.org/jeny/hanys/clabs20071024/CLABs.wmv) (Windows Media File Size: 157MB)
Note: For best performance you may wish to save this file to your computer (right-click on the link and choose to "Save As"). If you have any questions or problems listening to these audio-video recordings, please contact Nancy Landor (nlandor@hanys.org (mailto:nlandor@hanys.org)).
Biography
Chief, Infection Control and Hospital Epidemiologist, Beth Israel Medical Center; Attending Internal Medicine/Infectious Diseases, Beth Israel Medical Center; Associate Clinical Professor of Clinical Medicine, Albert Einstein College of Medicine.
Dr. Koll graduated from Brown University in 1982 and received his medical degree from George Washington University in 1986. He completed a Residency in Internal Medicine at Beth Israel Medical Center, New York, NY and a Fellowship in Infectious Diseases at Memorial Sloan-Kettering Cancer Center, New York, NY where he published on infections in patients with hematologic and solid tumors.
Dr. Koll has been in the Department of Infection Control at Beth Israel Medical Center since 1994 and is board-certified in Internal Medicine and Infectious Diseases. His research interests and clinical expertise include control and epidemiology of multi-drug resistant bacteria, prevention of healthcare acquired infections and emergency management as it relates to agents of bioterrorism, pandemic influenza and SARS.
He has had numerous CDC grants on prevention of exposures to bloodborne pathogens in healthcare workers, from the Public Health Research Institute studying S. aureus nasal carriage and infection of patients on hemodialysis, from the Agency for Healthcare Research and Quality on a trial to reduce antimicrobial prophylaxis errors, and most recently an NIH grant evaluating strategies to prevent spread of antibiotic resistant bacteria in the ICU setting.
Dr. Koll has served as Medical Consultant for GNYHA/UHF on their region-wide central line associated bloodstream infection (CLAB) collaborative, prevention of C. difficile collaborative, was a member of the NQF’s Hospital Acquired Infection Reporting and Implementation Technical Advisory Panel, is a member of New York State’s Department of Health’s Hospital Acquired Infection Technical Workgroup and has presented numerous abstracts on sustained reduction of CLABs at APIC, SHEA and the NPSF Patient Safety Congress.
His hospital is a mentor hospital for the IHI’s 5 Million Lives campaign and he was featured on the CBS Evening News with Dr. Donald Berwick of IHI regarding prevention of infections in hospitals. He was awarded a HANYs Pinnacle Award for Quality and Patient Safety, Honorable Mention for sustained reduction and elimination of CLABs across a hospital system in 2007.
Download video (http://webmedia.ipro.org/jeny/hanys/clabs20071024/CLABs.wmv) (Windows Media File Size: 157MB)
Note: For best performance you may wish to save this file to your computer (right-click on the link and choose to "Save As"). If you have any questions or problems listening to these audio-video recordings, please contact Nancy Landor (nlandor@hanys.org (mailto:nlandor@hanys.org)).
Biography
Chief, Infection Control and Hospital Epidemiologist, Beth Israel Medical Center; Attending Internal Medicine/Infectious Diseases, Beth Israel Medical Center; Associate Clinical Professor of Clinical Medicine, Albert Einstein College of Medicine.
Dr. Koll graduated from Brown University in 1982 and received his medical degree from George Washington University in 1986. He completed a Residency in Internal Medicine at Beth Israel Medical Center, New York, NY and a Fellowship in Infectious Diseases at Memorial Sloan-Kettering Cancer Center, New York, NY where he published on infections in patients with hematologic and solid tumors.
Dr. Koll has been in the Department of Infection Control at Beth Israel Medical Center since 1994 and is board-certified in Internal Medicine and Infectious Diseases. His research interests and clinical expertise include control and epidemiology of multi-drug resistant bacteria, prevention of healthcare acquired infections and emergency management as it relates to agents of bioterrorism, pandemic influenza and SARS.
He has had numerous CDC grants on prevention of exposures to bloodborne pathogens in healthcare workers, from the Public Health Research Institute studying S. aureus nasal carriage and infection of patients on hemodialysis, from the Agency for Healthcare Research and Quality on a trial to reduce antimicrobial prophylaxis errors, and most recently an NIH grant evaluating strategies to prevent spread of antibiotic resistant bacteria in the ICU setting.
Dr. Koll has served as Medical Consultant for GNYHA/UHF on their region-wide central line associated bloodstream infection (CLAB) collaborative, prevention of C. difficile collaborative, was a member of the NQF’s Hospital Acquired Infection Reporting and Implementation Technical Advisory Panel, is a member of New York State’s Department of Health’s Hospital Acquired Infection Technical Workgroup and has presented numerous abstracts on sustained reduction of CLABs at APIC, SHEA and the NPSF Patient Safety Congress.
His hospital is a mentor hospital for the IHI’s 5 Million Lives campaign and he was featured on the CBS Evening News with Dr. Donald Berwick of IHI regarding prevention of infections in hospitals. He was awarded a HANYs Pinnacle Award for Quality and Patient Safety, Honorable Mention for sustained reduction and elimination of CLABs across a hospital system in 2007.